Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...

So far this earnings season, companies in the S&P 500 that miss Wall Street's estimates for earnings per share and sales have ...

This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

Plains All American Pipeline, L.P. PAA is expected to report a decline in the top and bottom lines when it reports ...

Second-quarter earnings season is in full swing, and the results have been largely resilient so far. So why are stocks ...

Historically, the stock has reacted positively to its earnings reports, with a one-day price increase in 67% of instances ...

Kontoor (KTB) delivered earnings and revenue surprises of +40.70% and +4.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).

Q2 2025 Management View Paul Richards, EVP and CFO, reported "For the second quarter, we reported a net income of $0.54 per ...

Earnings jumped to $1.03 a share, up from $0.60 a year ago, as Emerson ( NYSE: EMR) improved its pretax margin by 570 basis ...

In Q2, the chipmaker's data center revenue grew just 14% year over year, versus 57% in Q1, due to the export controls that ...